262 related articles for article (PubMed ID: 32641243)
21. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
[TBL] [Abstract][Full Text] [Related]
22. PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Zerini D; Jereczek-Fossa BA; Ciabattoni A; Mirri A; Bertoni F; Fersino S; D'Agostino G; Lohr F; Mortellaro G; Triggiani L; Marvaso G; Pepa M; Cuccia F; Alongi F;
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2311-2317. PubMed ID: 32583236
[TBL] [Abstract][Full Text] [Related]
23. Re-irradiation with stereotactic body radiation therapy (SBRT).
Høyer M
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S15. PubMed ID: 28917253
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study.
Sasamura K; Suzuki R; Kozuka T; Yoshimura R; Yoshioka Y; Oguchi M
J Radiat Res; 2020 Nov; 61(6):929-934. PubMed ID: 32766715
[TBL] [Abstract][Full Text] [Related]
25. Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses.
Wang HH; Chen Y; Liu X; Zaorsky NG; Mani K; Niu ZM; Zheng BY; Zeng HY; Yan YY; Li YJ; He Y; Ji CZ; Sun BS; Meng MB
Radiother Oncol; 2023 Oct; 187():109817. PubMed ID: 37480993
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution Experience.
Macchia G; Pezzulla D; Cilla S; Buwenge M; Romano C; Ferro M; Boccardi M; Ferioli M; Bonome P; Lancellotta V; Tagliaferri L; Ferrandina G; Gambacorta MA; Morganti AG; Deodato F
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):682-693. PubMed ID: 37558548
[TBL] [Abstract][Full Text] [Related]
27. Salvage reirradiation for local prostate cancer recurrence after radiation therapy. For who? When? How?
Baty M; Créhange G; Pasquier D; Palard X; Deleuze A; Gnep K; Key S; Beuzit L; Castelli J; de Crevoisier R
Cancer Radiother; 2019 Oct; 23(6-7):541-558. PubMed ID: 31421999
[TBL] [Abstract][Full Text] [Related]
28. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
[TBL] [Abstract][Full Text] [Related]
30. Salvage stereotactic reirradiation for intraprostatic cancer recurrence: A large retrospective study.
Allali S; Loap P; Bibault JE; Krepps S; Deforge A; Moreau D; Durdux C; Giraud P
Prostate; 2023 Jun; 83(8):743-750. PubMed ID: 36911892
[TBL] [Abstract][Full Text] [Related]
31. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
32. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
33. Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
Sumodhee S; Bondiau PY; Poudenx M; Cohen C; Naghavi AO; Padovani B; Maneval D; Gal J; Leysalle A; Ghalloussi H; Otto J; Doyen J
BMC Cancer; 2019 Apr; 19(1):305. PubMed ID: 30943943
[TBL] [Abstract][Full Text] [Related]
34. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation.
Takagawa Y; Suzuki M; Seto I; Azami Y; Machida M; Takayama K; Sulaiman NS; Nakasato T; Kikuchi Y; Murakami M; Honda M; Teranishi Y; Kono K
J Radiat Res; 2024 May; 65(3):379-386. PubMed ID: 38604182
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
Chandy E; Taylor H; Gaito S; Wells E; Jones C; Meehan C; Burland H; Stone J; Snowball C; Mashru J; Riddell C; Hon Y; Welsh L; Saran F; Mandeville H
Clin Oncol (R Coll Radiol); 2020 May; 32(5):316-326. PubMed ID: 31813663
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
Muldermans JL; Romak LB; Kwon ED; Park SS; Olivier KR
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):696-702. PubMed ID: 27131082
[TBL] [Abstract][Full Text] [Related]
37. Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).
Lévy S; Chapet S; Scher N; Debbi K; Ruffier A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2017 Dec; 21(8):759-765. PubMed ID: 29128197
[TBL] [Abstract][Full Text] [Related]
38. A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma.
Ozyigit G; Cengiz M; Yazici G; Yildiz F; Gurkaynak M; Zorlu F; Yildiz D; Hosal S; Gullu I; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e263-8. PubMed ID: 21514737
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
